Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-XHER2
- Development stage
- Phase 1
- Lead developer
- First Affiliated Hospital of Xiamen University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals
- Administration
- Intravenous
01
Overview
68Ga-XHER2 is a novel gallium-68 (68Ga) radiolabeled positron emission tomography (PET) imaging tracer designed for the noninvasive assessment of human epidermal growth factor receptor 2 (HER2) expression in solid tumors. Developed by the First Affiliated Hospital of Xiamen University, the radiotracer binds specifically to HER2-expressing cancer cells, allowing for the quantification of HER2 expression levels via PET/CT imaging. This noninvasive approach aims to evaluate HER2 status across various solid tumors to guide targeted therapies, such as anti-HER2 monoclonal antibodies or antibody-drug conjugates, without the need for repeated invasive biopsies.
- Other names
- [68Ga]Ga-XHER2
02
Targets
ERBB2 (Erb-b2 receptor tyrosine kinase 2)
Beyond the preview
Go deeper on 68Ga-XHER2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-XHER2.